Clinical Trials Logo

Filter by:
NCT ID: NCT03257280 Recruiting - Gastric Cancer Clinical Trials

Trial on Impact on the Hospital Stay, of an Early Oral Nutrition Protocol Applied to Patients After Total Gastrectomy. (DOPGT_2015)

Start date: October 20, 2017
Phase: N/A
Study type: Interventional

This is a prospective randomized controlled clinical trial to clarify the effect of early oral nutrition introduction after total gastrectomy in gastric cancer patients on the length of hospital stay, comparing an experimental group vs control group.

NCT ID: NCT03256240 Recruiting - Crohn's Disease Clinical Trials

Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis

Start date: March 12, 2014
Phase: N/A
Study type: Interventional

This study proposes a randomized prospective study comparing the Kono-S anastomosis to the standard side-to-side anastomosis.This will be a multi-center randomized prospective trial. Patients with Crohn's ileitis or Crohn's ileocolitis requiring resection will be randomized to undergo either the Kono-S anastomosis or the side-to-side functional end anastomosis.

NCT ID: NCT03253263 Recruiting - Clinical trials for Bronchopulmonary Dysplasia

A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants

Start date: May 9, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if an investigational drug can prevent Bronchopulmonary Dysplasia, reducing the burden of chronic lung disease in extremely premature infants, as compared to extremely premature infants receiving standard neonatal care alone.

NCT ID: NCT03251365 Recruiting - Clinical trials for Resectable Pancreatic Adenocarcinoma

Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer

Start date: July 27, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

A randomized, multidisciplinary study, Phase II-III clinical trial.The study is opened to the incorporation of other centers that would increase the power of the obtained results . Our hypothesis considers that using Hyperthermic Intra-abdominal Chemotherapy,HIPEC, with gemcitabine after cytoreductive surgery ,will decrease tumor progression of pancreatic cancer by reducing the neoplastic volume and subpopulation of pancreatic cancer stem cells, improving the survival of patients with pancreatic cancer, and decreasing the recurrence of the disease

NCT ID: NCT03250338 Recruiting - Clinical trials for Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations

Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML

Start date: June 5, 2018
Phase: Phase 3
Study type: Interventional

This is a randomized, multi-center, double-blind, placebo-controlled study designed to evaluate the efficacy of crenolanib administered following salvage chemotherapy, consolidation chemotherapy, post bone marrow transplantation and as maintenance in relapsed/refractory AML subjects with FLT3 activating mutation.

NCT ID: NCT03249415 Recruiting - Asherman Syndrome Clinical Trials

Use of PRP in Endometrial Reconstruction

Start date: July 18, 2017
Phase:
Study type: Observational

Infertility, which affected 48.5 million couples worldwide in 2010 alone, has many causes; some causes result from issues related to the endometrium. Unfortunately, no cure exists for medical conditions resulting in the destruction of the endometrium, or for non-functional uterus. Thus, safe and effective therapies are needed to treat these diseases and to establish fertility in affected women. These novel techniques refer to the use and application of regenerative/paracrine factors to regenerate the endometrium in patients with Asherman's Syndrome (AS) and Endometrial Atrophy (EA).These new therapies based on the injection of the identified regenerative/paracrine factors and the platelet-rich plasma (PRP) from whole blood in an immunodeficient mouse model with AS/EA, evaluating their contribution and/or effect in the endometrial repair by functional proofs.

NCT ID: NCT03243409 Recruiting - Clinical trials for Proximal Humeral Fracture

Perioperative Complications in Reversed Shoulder Arthroplasties

Start date: July 25, 2017
Phase: N/A
Study type: Observational

Retrospective observational study of reversed shoulder arthroplasties by proximal humeral fracture. Analysis of preoperative risk factors as well as minor and major complications at the first week, 90 days and 1 year.

NCT ID: NCT03242382 Recruiting - Osteosarcoma Clinical Trials

Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.

PalboSarc
Start date: March 31, 2017
Phase: Phase 2
Study type: Interventional

Non-randomized, open, two-cohort, phase II, multicenter national clinical trial. 20 sites in Spain. Cohort 1 includes soft-tissue sarcoma and osteosarcoma (21 patients), while Cohort 2 includes chordoma patients only (19 patients). Palbociclib will be administered orally at a dose of 125 mg once a day for 21 consecutive days followed by 7 rest days to comprise a complete cycle of 28 days. Treatment will continue until disease progression, development of unacceptable toxicity, non-compliance, withdrawal of consent by the patient or investigator decision. The main goal is to determine progression-free survival rate (PFSR) according to RECIST 1.1 at 6 months.

NCT ID: NCT03237117 Recruiting - Female Infertility Clinical Trials

Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program

Start date: January 1, 2010
Phase: Early Phase 1
Study type: Interventional

105 infertile women are enrolled in the randomized controlled trial: 70 women with a history of RIF with donated oocytes and 35 infertile women undergoing the first oocyte donation attempt. Women receiving donated oocytes are treated with progressively increasing doses of oral estradiol followed by intravaginal progesterone after previous pituitary desensitization with GnRH agonist. 35 RIF patients are treated with GH (GH patients) while the rest 35 RIF patients (non-GH patients) and 35 first-attempt patients (positive control group) are not.

NCT ID: NCT03227523 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Nonspecific Low Back Pain in Association With Chronic Obstructive Pulmonary Disease

Start date: June 1, 2017
Phase: N/A
Study type: Observational

Introduction. Nonspecific low back pain (NSLBP) is a very prevalent medical condition, especially in subjects with chronic obstructive pulmonary disease (COPD). The diaphragm is a respiratory muscle, but it takes part in trunk stabilization on lumbar spine. NSLBP is related to lack of spinal control. The COPD symptoms include lack of efficiency in diaphragm, which could be connected to NSLBP. Hypothesis and objectives. COPD can contribute to NSLBP. It is associated with diaphragm weakness, severity of respiratory function, lower level of physical activity and quality of life in COPD. Methods. A descriptive observational cross-sectional study was conducted with two groups: the first one with subjects with COPD and the second one with subjects without it. Data were collected on: pulmonary function; respiratory muscles strength; trunk postural control; quality of life with COPD; physical activity level; lumbar pain presence, intensity and disability. Data were collected in a single session.